Can you take Wegovy (semaglutide) after gastric bypass surgery?
Yes, you can take Wegovy® after gastric bypass surgery. Patients who have had other bariatric surgical procedures including lap-band and gastric sleeve can also take the FDA-approved weight loss medication Wegovy. Wegovy (semaglutide) is in the class of medications called GLP-1 receptor agonists which also includes Saxenda® and Ozempic®. A post-bariatric weight regain study found that this class of medication was more effective for weight loss in patients who have had bariatric surgery than non-GLP-1 receptor agonist medications such as phentermine, Qsymia®, and Contrave®. A different study of patients who have had bariatric surgery in the past and were treated with semaglutide (up to 0.5 mg), demonstrated on average ~10% total body weight loss after 6 months.
Learn more about how Form Health doctors prescribe Wegovy to help patients achieve their weight loss goals.
Lauren Lemieux, MD, FACP, ABOM diplomate
Dr. Lauren Lemieux completed her Internal Medicine residency and fellowship in Clinical Nutrition at UCLA. She is board certified in Internal Medicine and diplomate of the American Board of Obesity Medicine, and as a Physician Nutrition Specialist. She is also a fellow of the American College of Physicians. Dr. Lemieux is passionate about helping her patients reach their health goals using personalized nutrition, lifestyle and weight management strategies.
Wegovy®, Saxenda®, and Ozempic® are registered trademarks of Novo Nordisk A/S.
Contrave® is a registered trademark of Currax Pharmaceuticals, LLC.
Qsymia® is a registered trademark of VIVUS LLC